XTSXBGA
Market cap9mUSD
Oct 19, Last price
0.12CAD
Name
BioNeutra Global Corp
Chart & Performance
Profile
BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company's lead product is VitaFiber, an isomalto-oligosaccharide functional and health food ingredient that offers low calorie soluble prebiotic fiber for human digestive health. It serves small and medium enterprises, and various food manufacturers in in Canada, the United States, Europe, Australia, New Zealand, and Southeast Asia. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. BioNeutra Global Corporation is based in Edmonton, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 11,383 -15.00% | 13,391 -13.05% | |||||||
Cost of revenue | 11,528 | 14,948 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (145) | (1,557) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 450 | ||||||||
Tax Rate | |||||||||
NOPAT | (145) | (2,008) | |||||||
Net income | (2,108) -27.86% | (2,921) 3.25% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 463 | 378 | |||||||
Long-term debt | 7,280 | 6,804 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 5,853 | 6,459 | |||||||
Cash flow | |||||||||
Cash from operating activities | 683 | 838 | |||||||
CAPEX | (19) | (204) | |||||||
Cash from investing activities | (21) | (197) | |||||||
Cash from financing activities | 446 | (309) | |||||||
FCF | 1,553 | 626 | |||||||
Balance | |||||||||
Cash | 1,890 | 723 | |||||||
Long term investments | |||||||||
Excess cash | 1,321 | 53 | |||||||
Stockholders' equity | (8,002) | (5,564) | |||||||
Invested Capital | 9,449 | 8,814 | |||||||
ROIC | |||||||||
ROCE | |||||||||
EV | |||||||||
Common stock shares outstanding | 46,449 | 46,449 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 913 | (446) | |||||||
EV/EBITDA | |||||||||
Interest | 697 | 450 | |||||||
Interest/NOPBT |